Article(id=1330225838571762631, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225816673301282, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2022.07.005, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1638288000000, receivedDateStr=2021-12-01, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795080154316, onlineDateStr=2026-11-19, pubDate=1657382400000, pubDateStr=2022-07-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795080154316, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795080154316, creator=13701087609, updateTime=1795080154316, updator=13701087609, issue=Issue{id=1330225816673301282, tenantId=1146029695717560320, journalId=1319690329412173987, year='2022', volume='43', issue='7', pageStart='815', pageEnd='956', issueExtLink='null', onlineDate='null', pubDate='1657382400000', pubDateStr='2022-07-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795080149094, creator='13701087609', updateTime=1795084753930, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330245131388695240, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225816673301282, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330245131388695241, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225816673301282, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=839, endPage=843, ext={EN=ArticleExt(id=1330225838785672136, articleId=1330225838571762631, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Clinical research progress of mesenchymal-epithelial transition factor inhibitor tepotinib, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Mesenchymal-epithelial transition factor (MET) is an important tumor driver gene in non-small cell lung cancer (NSCLC). In recent years, targeted therapy for MET signaling pathway has become a new target for lung cancer treatment. As the world's first oral, highly selective and potent MET inhibitor, tepotinib has been approved by Japan and the United States FDA for the treatment of advanced or recurrent NSCLC patients with unresectable and MET exon 14 skipping mutations. At the same time, it has shown good safety and efficacy in clinical studies. This article mainly reviewed the current clinical studies of tepotinib in NSCLC, liver cancer, NSCLC with brain metastasis and so on.

, authors=Yan REN1, 2, Lu WANG2, Ziwen DING2, Junlong WANG3, Jingyi FENG3, Yunliang QIU4, *, Na NI2, 3, *, authorsList=Yan REN, Lu WANG, Ziwen DING, Junlong WANG, Jingyi FENG, Yunliang QIU, Na NI, authorCompany=null, correspAuthors=Yunliang QIU, Na NI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330225839007970249, articleId=1330225838571762631, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=间质上皮细胞转化因子抑制剂特泊替尼的临床研究进展, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

间质上皮细胞转化因子(mesenchymal-epithelial transition factor,MET)是非小细胞肺癌(non-small cell lung cancer,NSCLC)的一种重要肿瘤驱动基因。近年来,针对MET信号传导通路的靶向治疗成为了肺癌治疗的新靶点。特泊替尼作为全球首个口服、高选择性、强效MET抑制剂,先后在日本和美国被批准用于不可切除、MET外显子14跳跃突变的晚期或复发性NSCLC患者的治疗,同时其在临床研究中亦表现出良好的安全性和有效性。该文主要对目前特泊替尼药物在NSCLC、肝癌及NSCLC伴脑转移等适应证的临床研究进行综述。

, authors=任燕1, 2, 汪璐2, 丁子文2, 王俊龙3, 冯静怡3, 邱云良4, *, 倪娜2, 3, *, authorsList=任燕, 汪璐, 丁子文, 王俊龙, 冯静怡, 邱云良, 倪娜, authorCompany=null, correspAuthors=邱云良, 倪娜, authorNote=

任燕,硕士研究生,研究方向:临床药学研究。

, correspAuthorsNote=
邱云良,研究员,研究方向:新药临床前评价研究。
倪娜,副研究员,研究方向:临床药学研究。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=s+J5/Up/bQe+/4o3I++oDg==, magXml=vwudrSgCIvVna6RLibT4Hg==, pdfUrl=null, pdf=U9iFfGbIsD8vC9GliMI60g==, pdfFileSize=1598422, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=p0+jBZxdPGT7lPxisS04aA==, mapNumber=null, fund=null)}, authors=[Author(id=1330225839540646871, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225839712613338, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225839540646871, language=EN, stringName=Yan REN, firstName=Yan, middleName=null, lastName=REN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.College of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai 201620, China
2.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225839783916507, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225839540646871, language=CN, stringName=任燕, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.上海工程技术大学化学化工学院,上海 201620
2.中国医药工业研究总院药物临床研究中心,上海 200437, bio={"content":"

任燕,硕士研究生,研究方向:临床药学研究。

"}, bioImg=null, bioContent=

任燕,硕士研究生,研究方向:临床药学研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225839196713930, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=1., ext=[AuthorCompanyExt(id=1330225839200908235, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839196713930, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.College of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai 201620, China), AuthorCompanyExt(id=1330225839209296844, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839196713930, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海工程技术大学化学化工学院,上海 201620)]), AuthorCompany(id=1330225839288988621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=2., ext=[AuthorCompanyExt(id=1330225839301571534, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839288988621, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225839309960143, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839288988621, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1330225839851025373, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225839926522847, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225839851025373, language=EN, stringName=Lu WANG, firstName=Lu, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225839997826016, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225839851025373, language=CN, stringName=汪璐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.中国医药工业研究总院药物临床研究中心,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225839288988621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=2., ext=[AuthorCompanyExt(id=1330225839301571534, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839288988621, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225839309960143, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839288988621, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1330225840056546274, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225840144626660, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225840056546274, language=EN, stringName=Ziwen DING, firstName=Ziwen, middleName=null, lastName=DING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225840211735526, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225840056546274, language=CN, stringName=丁子文, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.中国医药工业研究总院药物临床研究中心,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225839288988621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=2., ext=[AuthorCompanyExt(id=1330225839301571534, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839288988621, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225839309960143, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839288988621, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1330225840278844392, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225840350147562, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225840278844392, language=EN, stringName=Junlong WANG, firstName=Junlong, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225840429839339, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225840278844392, language=CN, stringName=王俊龙, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.上海瀛科隆医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225839377069008, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=3., ext=[AuthorCompanyExt(id=1330225839381263313, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839377069008, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China), AuthorCompanyExt(id=1330225839389651922, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839377069008, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海瀛科隆医药开发有限公司,上海 200437)])]), Author(id=1330225840505336813, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225840660526063, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225840505336813, language=EN, stringName=Jingyi FENG, firstName=Jingyi, middleName=null, lastName=FENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225840719246320, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225840505336813, language=CN, stringName=冯静怡, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.上海瀛科隆医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225839377069008, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=3., ext=[AuthorCompanyExt(id=1330225839381263313, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839377069008, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China), AuthorCompanyExt(id=1330225839389651922, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839377069008, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海瀛科隆医药开发有限公司,上海 200437)])]), Author(id=1330225840777966578, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225840916378612, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225840777966578, language=EN, stringName=Yunliang QIU, firstName=Yunliang, middleName=null, lastName=QIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=4, *, address=4.Shanghai Innostar Biotechnology Co., Ltd., Shanghai 201203, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225842531185654, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225840777966578, language=CN, stringName=邱云良, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=4, *, address=4.上海益诺思生物技术股份有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225839448372179, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=4., ext=[AuthorCompanyExt(id=1330225839460955092, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839448372179, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.Shanghai Innostar Biotechnology Co., Ltd., Shanghai 201203, China), AuthorCompanyExt(id=1330225839465149397, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839448372179, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.上海益诺思生物技术股份有限公司,上海 201203)])]), Author(id=1330225842598294520, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, orderNo=6, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225842686374907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225842598294520, language=EN, stringName=Na NI, firstName=Na, middleName=null, lastName=NI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, 3, *, address=2.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
3.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225842757678076, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225842598294520, language=CN, stringName=倪娜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, 3, *, address=2.中国医药工业研究总院药物临床研究中心,上海 200437
3.上海瀛科隆医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225839288988621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=2., ext=[AuthorCompanyExt(id=1330225839301571534, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839288988621, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225839309960143, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839288988621, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业研究总院药物临床研究中心,上海 200437)]), AuthorCompany(id=1330225839377069008, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=3., ext=[AuthorCompanyExt(id=1330225839381263313, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839377069008, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China), AuthorCompanyExt(id=1330225839389651922, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839377069008, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海瀛科隆医药开发有限公司,上海 200437)])])], keywords=[Keyword(id=1330225842858341373, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, language=EN, orderNo=1, keyword=mesenchymal-epithelial transition factor inhibitor), Keyword(id=1330225842917061630, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, language=EN, orderNo=2, keyword=tepotinib), Keyword(id=1330225842971587583, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, language=EN, orderNo=3, keyword=clinical research), Keyword(id=1330225843034502144, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, language=EN, orderNo=4, keyword=antineoplastic), Keyword(id=1330225843101609984, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, language=CN, orderNo=1, keyword=间质上皮细胞转化因子抑制剂), Keyword(id=1330225843156135937, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, language=CN, orderNo=2, keyword=特泊替尼), Keyword(id=1330225843206467586, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, language=CN, orderNo=3, keyword=临床研究), Keyword(id=1330225843273576451, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, language=CN, orderNo=4, keyword=抗肿瘤药)], refs=[Reference(id=1330225843391016964, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Bouattour M, Raymond E, Qin S, et al. Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma[J]. Hepatology, 2018, 67(3): 1132-1149., articleTitle=null, refAbstract=null), Reference(id=1330225843453931525, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Garon EB, Brodrick P. Targeted therapy approaches for MET abnormalities in non-small cell lung cancer[J]. Drugs, 2021, 81(5): 547-554., articleTitle=null, refAbstract=null), Reference(id=1330225843521040391, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Zorzetto M, Ferrari S, Saracino L, et al. MET genetic lesions in non-small-cell lung cancer: pharmacological and clinical implications[J]. Transl Lung Cancer Res, 2012, 1(3): 194-207., articleTitle=null, refAbstract=null), Reference(id=1330225847014895625, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Recondo G, Che J, Janne PA, et al. Targeting MET dysregulation in cancer[J]. Cancer Discov, 2020, 10(7): 922-934., articleTitle=null, refAbstract=null), Reference(id=1330225847132336138, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Frampton GM, Ali SM, Rosenzweig M, et al. Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors[J]. Cancer Discov, 2015, 5(8): 850-859., articleTitle=null, refAbstract=null), Reference(id=1330225847224610827, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Paik PK, Drilon A, Fan PD, et al. Re-sponse to MET inhibitors in patients with stage Ⅳ lung adenocarcinomas harboring MET mutations causing exon 14 skipping[J]. Cancer Discov, 2015, 5(8): 842-849., articleTitle=null, refAbstract=null), Reference(id=1330225847300108300, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Awad MM, Oxnard GR, Jackman DM, et al. MET exon 14 mutations in non-small-cell lung cancer are associated with advanced age and stage-dependent MET genomic amplification and c-Met over-expression[J]. J Clin Oncol, 2016, 34(7): 721-730., articleTitle=null, refAbstract=null), Reference(id=1330225847363022861, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Markham A. Tepotinib: first approval[J]. Drugs, 2020, 80(8): 829-833., articleTitle=null, refAbstract=null), Reference(id=1330225847425937422, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Wu ZX, Teng QX, Cai CY, et al. Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells[J]. Biochem Pharmacol, 2019, 166: 120-127., articleTitle=null, refAbstract=null), Reference(id=1330225847497240591, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Lee J, Ou SH, Lee JM, et al. Gastrointestinal malignan cies harbor actionable MET exon 14 deletions[J]. Oncotarget, 2015, 6(29): 28211-28222., articleTitle=null, refAbstract=null), Reference(id=1330225847560155152, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Falchook GS, Kurzrock R, Amin HM, et al. First-in-man phase Ⅰ trial of the selective MET inhibitor tepotinib in patients with advanced solid tumors[J]. Clin Cancer Res, 2020, 26(6): 1237-1246., articleTitle=null, refAbstract=null), Reference(id=1330225847627264017, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Shitara K, Yamazaki K, Tsushima T, et al. PhaseⅠ trial of the MET inhibitor tepotinib in Japanese patients with solid tumors[J]. Jpn J Clin Oncol, 2020, 50(8): 859-866., articleTitle=null, refAbstract=null), Reference(id=1330225847694372882, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Paik PK, Felip E, Veillon R, et al. Tepotinib in non-small-cell lung cancer with MET exon 14 skipping mutations[J]. N Engl J Med, 2020, 383(10): 931-943., articleTitle=null, refAbstract=null), Reference(id=1330225847765676051, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Sakai H, Morise M, Kato T. et al. Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the phase Ⅱ vision study[J]. Jpn J Clin Oncol, 2021, 51(8): 1261-1268., articleTitle=null, refAbstract=null), Reference(id=1330225847836979220, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Wu YL, Cheng Y, Zhou J, et al. Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial[J]. Lancet Respir Med, 2020, 8(11): 1132-1143., articleTitle=null, refAbstract=null), Reference(id=1330225847899893781, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Ryoo BY, Cheng AL, Ren Z, et al. Randomised phase 1b/2 trial of tepotinib vs sorafenib in asian patients with advanced hepatocellular carcinoma with MET overexpression[J]. Br J Cancer, 2021, 125(2): 200-208., articleTitle=null, refAbstract=null), Reference(id=1330225847967002646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Decaens T, Barone C, Assenat E, et al. Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression[J]. Br J Cancer, 2021, 125(2): 190-199., articleTitle=null, refAbstract=null), Reference(id=1330225848029917207, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Blanc-Durand F, Alameddine R, et al. Tepotinib efficacy in a patient with non-small cell lung cancer with brain metastasis harboring an HLA-DRB1-MET gene fusion[J]. Oncologist, 2020, 25(11): 916-920., articleTitle=null, refAbstract=null), Reference(id=1330225848092831768, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Takamori S, Matsubara T, Fujishita T, et al. Dramatic intracranial response to tepotinib in a patient with lung adenocarcinoma harboring MET exon 14 skipping mutation[J]. Thorac Cancer, 2021, 12(6): 978-980., articleTitle=null, refAbstract=null), Reference(id=1330225848151552025, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Tanaka H, Taima K, Makiguchi T. et al. Activity and bioavailability of tepotinib for leptomeningeal metastasis of NSCLC with MET exon 14 skipping mutation[J]. Cancer Commun (Lond), 2021, 41(1): 83-87., articleTitle=null, refAbstract=null), Reference(id=1330225848210272282, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Jia H, Dai G, Weng J, et al. Discovery of (S)-1-{1-[imidazo-(1, 2-a) pyridin-6-yl]ethyl}-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1, 2, 3) triazolo (4, 5-b) pyrazine (volitinib) as a highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitor in clinical development for treatment of cancer[J]. J Med Chem, 2014, 57(18): 7577-7589., articleTitle=null, refAbstract=null), Reference(id=1330225848289964059, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Gavine PR, Ren Y, Han L, et al. Volitinib, a potent and highly selective c-Met inhibitor, effectively blocks c-Met signaling and growth in c-MET amplified gastric cancer patient-derived tumor xenograft models[J]. Mol Oncol, 2015, 9(1): 323-333., articleTitle=null, refAbstract=null), Reference(id=1330225848373850140, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Lu S, Fang J, Li X, et al. Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study[J]. Lancet Respir Med, 2021, 9(10): 1154-1164., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330225839196713930, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=1., ext=[AuthorCompanyExt(id=1330225839200908235, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839196713930, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.College of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai 201620, China), AuthorCompanyExt(id=1330225839209296844, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839196713930, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海工程技术大学化学化工学院,上海 201620)]), AuthorCompany(id=1330225839288988621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=2., ext=[AuthorCompanyExt(id=1330225839301571534, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839288988621, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225839309960143, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839288988621, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业研究总院药物临床研究中心,上海 200437)]), AuthorCompany(id=1330225839377069008, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=3., ext=[AuthorCompanyExt(id=1330225839381263313, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839377069008, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China), AuthorCompanyExt(id=1330225839389651922, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839377069008, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海瀛科隆医药开发有限公司,上海 200437)]), AuthorCompany(id=1330225839448372179, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=4., ext=[AuthorCompanyExt(id=1330225839460955092, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839448372179, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.Shanghai Innostar Biotechnology Co., Ltd., Shanghai 201203, China), AuthorCompanyExt(id=1330225839465149397, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839448372179, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.上海益诺思生物技术股份有限公司,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.07.005, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.07.005, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2022.07.005, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2022.07.005, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1657382400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
间质上皮细胞转化因子抑制剂特泊替尼的临床研究进展
任燕 1, 2 , 汪璐 2 , 丁子文 2 , 王俊龙 3 , 冯静怡 3 , 邱云良 4, * , 倪娜 2, 3, *
世界临床药物 | 医药专论 2022,43(7): 839-843
收起
收藏切换
世界临床药物 |医药专论 2022 , 43 (7) : 839 -843
间质上皮细胞转化因子抑制剂特泊替尼的临床研究进展
全屏
[Author(id=1330225839540646871, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225839712613338, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225839540646871, language=EN, stringName=Yan REN, firstName=Yan, middleName=null, lastName=REN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.College of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai 201620, China
2.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225839783916507, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225839540646871, language=CN, stringName=任燕, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.上海工程技术大学化学化工学院,上海 201620
2.中国医药工业研究总院药物临床研究中心,上海 200437, bio={"content":"

任燕,硕士研究生,研究方向:临床药学研究。

"}, bioImg=null, bioContent=

任燕,硕士研究生,研究方向:临床药学研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225839196713930, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=1., ext=[AuthorCompanyExt(id=1330225839200908235, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839196713930, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.College of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai 201620, China), AuthorCompanyExt(id=1330225839209296844, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839196713930, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海工程技术大学化学化工学院,上海 201620)]), AuthorCompany(id=1330225839288988621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=2., ext=[AuthorCompanyExt(id=1330225839301571534, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839288988621, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225839309960143, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839288988621, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1330225839851025373, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225839926522847, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225839851025373, language=EN, stringName=Lu WANG, firstName=Lu, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225839997826016, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225839851025373, language=CN, stringName=汪璐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.中国医药工业研究总院药物临床研究中心,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225839288988621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=2., ext=[AuthorCompanyExt(id=1330225839301571534, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839288988621, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225839309960143, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839288988621, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1330225840056546274, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225840144626660, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225840056546274, language=EN, stringName=Ziwen DING, firstName=Ziwen, middleName=null, lastName=DING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225840211735526, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225840056546274, language=CN, stringName=丁子文, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.中国医药工业研究总院药物临床研究中心,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225839288988621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=2., ext=[AuthorCompanyExt(id=1330225839301571534, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839288988621, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225839309960143, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839288988621, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业研究总院药物临床研究中心,上海 200437)])]), Author(id=1330225840278844392, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225840350147562, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225840278844392, language=EN, stringName=Junlong WANG, firstName=Junlong, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225840429839339, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225840278844392, language=CN, stringName=王俊龙, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.上海瀛科隆医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225839377069008, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=3., ext=[AuthorCompanyExt(id=1330225839381263313, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839377069008, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China), AuthorCompanyExt(id=1330225839389651922, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839377069008, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海瀛科隆医药开发有限公司,上海 200437)])]), Author(id=1330225840505336813, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225840660526063, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225840505336813, language=EN, stringName=Jingyi FENG, firstName=Jingyi, middleName=null, lastName=FENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225840719246320, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225840505336813, language=CN, stringName=冯静怡, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.上海瀛科隆医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225839377069008, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=3., ext=[AuthorCompanyExt(id=1330225839381263313, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839377069008, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China), AuthorCompanyExt(id=1330225839389651922, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839377069008, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海瀛科隆医药开发有限公司,上海 200437)])]), Author(id=1330225840777966578, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225840916378612, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225840777966578, language=EN, stringName=Yunliang QIU, firstName=Yunliang, middleName=null, lastName=QIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=4, *, address=4.Shanghai Innostar Biotechnology Co., Ltd., Shanghai 201203, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225842531185654, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225840777966578, language=CN, stringName=邱云良, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=4, *, address=4.上海益诺思生物技术股份有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225839448372179, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=4., ext=[AuthorCompanyExt(id=1330225839460955092, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839448372179, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.Shanghai Innostar Biotechnology Co., Ltd., Shanghai 201203, China), AuthorCompanyExt(id=1330225839465149397, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839448372179, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.上海益诺思生物技术股份有限公司,上海 201203)])]), Author(id=1330225842598294520, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, orderNo=6, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225842686374907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225842598294520, language=EN, stringName=Na NI, firstName=Na, middleName=null, lastName=NI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, 3, *, address=2.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
3.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225842757678076, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, authorId=1330225842598294520, language=CN, stringName=倪娜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, 3, *, address=2.中国医药工业研究总院药物临床研究中心,上海 200437
3.上海瀛科隆医药开发有限公司,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225839288988621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=2., ext=[AuthorCompanyExt(id=1330225839301571534, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839288988621, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1330225839309960143, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839288988621, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国医药工业研究总院药物临床研究中心,上海 200437)]), AuthorCompany(id=1330225839377069008, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, xref=3., ext=[AuthorCompanyExt(id=1330225839381263313, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839377069008, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China), AuthorCompanyExt(id=1330225839389651922, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225838571762631, companyId=1330225839377069008, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海瀛科隆医药开发有限公司,上海 200437)])])]
任燕1, 2, 汪璐2, 丁子文2, 王俊龙3, 冯静怡3, 邱云良4, *, 倪娜2, 3, *
作者信息
  • 1.上海工程技术大学化学化工学院,上海 201620
  • 2.中国医药工业研究总院药物临床研究中心,上海 200437
  • 3.上海瀛科隆医药开发有限公司,上海 200437
  • 4.上海益诺思生物技术股份有限公司,上海 201203
通讯作者:
邱云良,研究员,研究方向:新药临床前评价研究。
倪娜,副研究员,研究方向:临床药学研究。
作者简介:

任燕,硕士研究生,研究方向:临床药学研究。

Clinical research progress of mesenchymal-epithelial transition factor inhibitor tepotinib
Yan REN1, 2, Lu WANG2, Ziwen DING2, Junlong WANG3, Jingyi FENG3, Yunliang QIU4, *, Na NI2, 3, *
Affiliations
  • 1.College of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai 201620, China
  • 2.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
  • 3.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China
  • 4.Shanghai Innostar Biotechnology Co., Ltd., Shanghai 201203, China
出版时间: 2022-07-10 doi: 10.13683/j.wph.2022.07.005
文章导航
收藏切换

间质上皮细胞转化因子(mesenchymal-epithelial transition factor,MET)是非小细胞肺癌(non-small cell lung cancer,NSCLC)的一种重要肿瘤驱动基因。近年来,针对MET信号传导通路的靶向治疗成为了肺癌治疗的新靶点。特泊替尼作为全球首个口服、高选择性、强效MET抑制剂,先后在日本和美国被批准用于不可切除、MET外显子14跳跃突变的晚期或复发性NSCLC患者的治疗,同时其在临床研究中亦表现出良好的安全性和有效性。该文主要对目前特泊替尼药物在NSCLC、肝癌及NSCLC伴脑转移等适应证的临床研究进行综述。

间质上皮细胞转化因子抑制剂  /  特泊替尼  /  临床研究  /  抗肿瘤药

Mesenchymal-epithelial transition factor (MET) is an important tumor driver gene in non-small cell lung cancer (NSCLC). In recent years, targeted therapy for MET signaling pathway has become a new target for lung cancer treatment. As the world's first oral, highly selective and potent MET inhibitor, tepotinib has been approved by Japan and the United States FDA for the treatment of advanced or recurrent NSCLC patients with unresectable and MET exon 14 skipping mutations. At the same time, it has shown good safety and efficacy in clinical studies. This article mainly reviewed the current clinical studies of tepotinib in NSCLC, liver cancer, NSCLC with brain metastasis and so on.

mesenchymal-epithelial transition factor inhibitor  /  tepotinib  /  clinical research  /  antineoplastic
任燕, 汪璐, 丁子文, 王俊龙, 冯静怡, 邱云良, 倪娜. 间质上皮细胞转化因子抑制剂特泊替尼的临床研究进展. 世界临床药物, 2022 , 43 (7) : 839 -843 . DOI: 10.13683/j.wph.2022.07.005
Yan REN, Lu WANG, Ziwen DING, Junlong WANG, Jingyi FENG, Yunliang QIU, Na NI. Clinical research progress of mesenchymal-epithelial transition factor inhibitor tepotinib[J]. World Clinical Drug, 2022 , 43 (7) : 839 -843 . DOI: 10.13683/j.wph.2022.07.005

参考文献 引证文献
排序方式:
[1]
Bouattour M, Raymond E, Qin S, et al. Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma[J]. Hepatology, 2018, 67(3): 1132-1149.
[2]
Garon EB, Brodrick P. Targeted therapy approaches for MET abnormalities in non-small cell lung cancer[J]. Drugs, 2021, 81(5): 547-554.
[3]
Zorzetto M, Ferrari S, Saracino L, et al. MET genetic lesions in non-small-cell lung cancer: pharmacological and clinical implications[J]. Transl Lung Cancer Res, 2012, 1(3): 194-207.
[4]
Recondo G, Che J, Janne PA, et al. Targeting MET dysregulation in cancer[J]. Cancer Discov, 2020, 10(7): 922-934.
[5]
Frampton GM, Ali SM, Rosenzweig M, et al. Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors[J]. Cancer Discov, 2015, 5(8): 850-859.
[6]
Paik PK, Drilon A, Fan PD, et al. Re-sponse to MET inhibitors in patients with stage Ⅳ lung adenocarcinomas harboring MET mutations causing exon 14 skipping[J]. Cancer Discov, 2015, 5(8): 842-849.
[7]
Awad MM, Oxnard GR, Jackman DM, et al. MET exon 14 mutations in non-small-cell lung cancer are associated with advanced age and stage-dependent MET genomic amplification and c-Met over-expression[J]. J Clin Oncol, 2016, 34(7): 721-730.
[8]
Markham A. Tepotinib: first approval[J]. Drugs, 2020, 80(8): 829-833.
[9]
Wu ZX, Teng QX, Cai CY, et al. Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells[J]. Biochem Pharmacol, 2019, 166: 120-127.
[10]
Lee J, Ou SH, Lee JM, et al. Gastrointestinal malignan cies harbor actionable MET exon 14 deletions[J]. Oncotarget, 2015, 6(29): 28211-28222.
[11]
Falchook GS, Kurzrock R, Amin HM, et al. First-in-man phase Ⅰ trial of the selective MET inhibitor tepotinib in patients with advanced solid tumors[J]. Clin Cancer Res, 2020, 26(6): 1237-1246.
[12]
Shitara K, Yamazaki K, Tsushima T, et al. PhaseⅠ trial of the MET inhibitor tepotinib in Japanese patients with solid tumors[J]. Jpn J Clin Oncol, 2020, 50(8): 859-866.
[13]
Paik PK, Felip E, Veillon R, et al. Tepotinib in non-small-cell lung cancer with MET exon 14 skipping mutations[J]. N Engl J Med, 2020, 383(10): 931-943.
[14]
Sakai H, Morise M, Kato T. et al. Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the phase Ⅱ vision study[J]. Jpn J Clin Oncol, 2021, 51(8): 1261-1268.
[15]
Wu YL, Cheng Y, Zhou J, et al. Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial[J]. Lancet Respir Med, 2020, 8(11): 1132-1143.
[16]
Ryoo BY, Cheng AL, Ren Z, et al. Randomised phase 1b/2 trial of tepotinib vs sorafenib in asian patients with advanced hepatocellular carcinoma with MET overexpression[J]. Br J Cancer, 2021, 125(2): 200-208.
[17]
Decaens T, Barone C, Assenat E, et al. Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression[J]. Br J Cancer, 2021, 125(2): 190-199.
[18]
Blanc-Durand F, Alameddine R, et al. Tepotinib efficacy in a patient with non-small cell lung cancer with brain metastasis harboring an HLA-DRB1-MET gene fusion[J]. Oncologist, 2020, 25(11): 916-920.
[19]
Takamori S, Matsubara T, Fujishita T, et al. Dramatic intracranial response to tepotinib in a patient with lung adenocarcinoma harboring MET exon 14 skipping mutation[J]. Thorac Cancer, 2021, 12(6): 978-980.
[20]
Tanaka H, Taima K, Makiguchi T. et al. Activity and bioavailability of tepotinib for leptomeningeal metastasis of NSCLC with MET exon 14 skipping mutation[J]. Cancer Commun (Lond), 2021, 41(1): 83-87.
[21]
Jia H, Dai G, Weng J, et al. Discovery of (S)-1-{1-[imidazo-(1, 2-a) pyridin-6-yl]ethyl}-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1, 2, 3) triazolo (4, 5-b) pyrazine (volitinib) as a highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitor in clinical development for treatment of cancer[J]. J Med Chem, 2014, 57(18): 7577-7589.
[22]
Gavine PR, Ren Y, Han L, et al. Volitinib, a potent and highly selective c-Met inhibitor, effectively blocks c-Met signaling and growth in c-MET amplified gastric cancer patient-derived tumor xenograft models[J]. Mol Oncol, 2015, 9(1): 323-333.
[23]
Lu S, Fang J, Li X, et al. Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study[J]. Lancet Respir Med, 2021, 9(10): 1154-1164.
2022年第43卷第7期
10
1
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2022.07.005
  • 接收时间:2021-12-01
  • 首发时间:2026-11-19
  • 出版时间:2022-07-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2021-12-01
基金
作者信息
    1.上海工程技术大学化学化工学院,上海 201620
    2.中国医药工业研究总院药物临床研究中心,上海 200437
    3.上海瀛科隆医药开发有限公司,上海 200437
    4.上海益诺思生物技术股份有限公司,上海 201203

通讯作者:

邱云良,研究员,研究方向:新药临床前评价研究。
倪娜,副研究员,研究方向:临床药学研究。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.07.005
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏